TANYA UNDERWOOD: Open Payments
NPI 1366062572 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 12 payments from 8 companies in 2025. Trend: 2023 $439 · 2024 $203 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $78 |
| MILLICENT US INC | 3 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $42 |
| Hologic Sales and Service, LLC | 1 | $32 |
| Astellas Pharma US Inc | 1 | $19 |
| Biogen, Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, INTRAROSA, OMNI HYSTEROSCOPE, Veozah, ZURZUVAE, ACCRUFER, LILETTA, FEMRING.
Industry payments across MS — which companies pay providers there.
